Elite Pharmaceuticals (ELTP) Non Operating Income (2010 - 2026)
Elite Pharmaceuticals (ELTP) reported Non Operating Income of $187,261 for fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$22.26 million a year earlier and down 98.2% from the prior quarter.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) Non Operating Income (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Elite Pharmaceuticals' Non Operating Income came in at $30.15 million; for FY2026 (ended Mar 31, 2026), it came in at $7.7 million.
- Non Operating Income has a five-year compound annual growth rate of 30.4% (FY2021 to FY2026).
- By fiscal year, Non Operating Income came in at -$19.65 million in FY2025, -$10.33 million in FY2024, $309,872 in FY2023 (-74.9%) and $1.23 million in FY2022 (-39.5%).
- Five-year quarterly Non Operating Income spans a low of -$22.26 million in fiscal Q1 2026 and a high of $11.82 million in fiscal Q3 2026.
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $10.67 million (Q4 2026), $11.82 million (Q3 2026) and $7.48 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 269.00 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | - |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | -73.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 387.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Elite Pharmaceuticals | 268.12 Mn | 149.80 Mn | 13.51 Mn | 187,261.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 187,261.00 |
| Mar 31, 2026 | 10.67 Mn |
| Dec 31, 2025 | 11.82 Mn |
| Sep 30, 2025 | 7.48 Mn |
| Jun 30, 2025 | -22.26 Mn |
| Mar 31, 2025 | 8.12 Mn |
| Dec 31, 2024 | -11.75 Mn |
| Sep 30, 2024 | -13.00 Mn |
| Jun 30, 2024 | -3.02 Mn |
| Mar 31, 2024 | -1.74 Mn |
| Dec 31, 2023 | -3.63 Mn |
| Sep 30, 2023 | -4.66 Mn |
| Jun 30, 2023 | -305,263.00 |
| Mar 31, 2023 | -469,164.00 |
| Dec 31, 2022 | 1.05 Mn |
| Sep 30, 2022 | 445,609.00 |
| Jun 30, 2022 | -716,801.00 |
| Mar 31, 2022 | -163,376.00 |
| Dec 31, 2021 | 452,113.00 |
| Sep 30, 2021 | 376,371.00 |
API Access
Elite Pharmaceuticals Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();